Press Releases

Huateng Pharma Announced To Attend INTERPEHX Week Tokyo - in-PHARMA JAPAN In July 2023

Jun 20, 2023, 10:57 AM by
Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB.

Huateng Pharma, a professional supplier for PEG derivatives, PEG raw materials and pharmaceutical intermediates, provides global customers with high quality products and best service. Recently it announced its attendance at the upcoming INTERPEHX Week Tokyo - in-PHARMA JAPAN. This three-day event will take place at Tokyo Big Sight, Japan from 5th-7th July, 2023.

Huateng Pharma is a one-stop contract development and manufacturing organization (CDMO) for pharmaceutical intermediates and PEG derivatives from clinical supply to commercial scale. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production. We also have established a 5000 square meters R&D center , equipped with nearly 100 sets of high-end analytical and testing instruments and automatic reaction equipment.

“We are so glad that we will attend the INTERPEHX Week Tokyo - in-PHARMA JAPAN in July, so we will have the chance to communicate with our customers face-to-face. "said a senior manager at Huateng Pharma. "We look forward to interacting with our customers face to face, sharing updates on our plant's progress and presenting our plant's capacity."

Basic Information about the INTERPEHX Week Tokyo - in-PHARMA JAPAN

Date: 5 - 7 July, 2023

Booth: 2-10

Location: Tokyo Big Sight, Japan

Huateng Pharma, founded in 2013, is a one-stop contract development and manufacturing organization (CDMO) to manufacture and supply researchers with pharmaceutical intermediatesPEG raw materials & PEG derivatives and products used across the pharmaceutical value chain including intermediates, excipients, APIs, and reagents.

Pharmaceutical Intermediates: Offer pharma intermediates'process development and scale-up production with capacities varying from gram to kilograms and multi tons.

PEG Deriavtives: Stock of 3000+ high-quality PEG derivatives, monodispersed PEG linkers, multi-arm PEGs from R&D through GMP commercial scale.

 

Learn more:

https://us.huatengsci.com